Topical Anti-Inflammatory Treatments for Atopic Dermatitis
JAMA Dermatology · 2026
DOI: 10.1001/jamadermatol.2025.3986 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, 2026. Verfasst von Rachel Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Dermatitis, Atopic. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Clinical Question Which topical anti-inflammatory treatments are most effective and safe for managing atopic dermatitis? Bottom Line In a network meta-analyses, very potent/potent topical corticosteroids; tacrolimus, 0.1%; and topical Janus kinase inhibitors were among the most effective treatments for short-term control of atopic dermatitis symptoms, while phosphodiesterase-4 inhibitors were among the least effective. Topical calcineurin inhibitors and crisaborole were associated with application-site irritation, and short-term topical steroid use was not associated with skin thinning. However, these findings were of low to moderate certainty, and longer-term data remain limited for many agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- University of Arizona Phoenix School of Medicine, Phoenix.
Zitieren
APA
Zhang, R., & Wan, J. (2026). Topical Anti-Inflammatory Treatments for Atopic Dermatitis. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2025.3986
Vancouver
Zhang R, Wan J. Topical Anti-Inflammatory Treatments for Atopic Dermatitis. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2025.3986
BibTeX
@article{Zhang2026,
author = {Zhang, Rachel and Wan, Joy},
title = {Topical Anti-Inflammatory Treatments for Atopic Dermatitis},
journal = {JAMA Dermatology},
year = {2026},
doi = {10.1001/jamadermatol.2025.3986}
}
EUVIMED